Medicaid State Drug Utilization Data
Centers for Medicare & Medicaid Services (CMS)
Every drug Medicaid paid for, by state and quarter, down to the package code.
Quarterly data that states report to CMS under the Medicaid Drug Rebate Program, listing the number of prescriptions, units, and amount reimbursed for each drug (by National Drug Code) in each state. It covers fee-for-service and managed care. Analysts use it to track spending on specific drugs such as insulin, hepatitis C cures, or GLP-1s.
Access
- Cost
- FreeNo charge; downloadable from data.medicaid.gov with an API.
- License
- Public domainPublic domain (U.S. government work)
- Sign-up
- No sign-up
- How you get it
- API and Bulk downloadCSV
What's in it
- One row is
- One row per state, quarter, NDC, and utilization type (fee-for-service or managed care)
- Covers
- All US states and DC
- Years
- 1991-present
- Updated
- Quarterly
- Size
- Not stated
Quality
Long history and full drug detail, but amounts are before rebates and small counts are redacted.
- Spending is before manufacturer rebates, which are large for brand drugs
- Rows with fewer than 11 prescriptions are suppressed
- State reporting quality varies
Connects to
- Medicare Part D Prescribers by Provider and Drug: The Medicare counterpart for comparing drug use
- RxNorm: Map NDCs to ingredients and drug classes
- FDA Orange Book: Identify brand versus generic and patent status
Questions it could answer
- How fast did Medicaid spending on GLP-1 drugs grow in each state?
- Which states spend the most per enrollee on brand-name insulin?